Back to Search
WENDY HANNA, M.D.
M.D.
Emergency Medicine Physician
NPI: 1457610651IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MD2018-0820(NM)RS002870(OH)2016027983(MO)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 2012
Research & Publications (20)
Intraoperative consultation for axillary sentinel lymph node biopsy: an 8-year audit.
PMID 19223378·Int J Surg Pathol·2010
8-other
Pattern of metastatic spread in triple-negative breast cancer.
PMID 18543098·Breast Cancer Res Treat·2009
8-other
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.
PMID 19189211·Breast Cancer Res Treat·2009
4-observational
Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients.
PMID 19255333·J Clin Oncol·2009
6-review
In vitro and in vivo evaluation of ferric-hyaluronate implants for delivery of amikacin sulfate to the tarsocrural joint of horses.
PMID 19538672·Vet Surg·2009
2-rct
Immunophenotyping of serous carcinoma of the female genital tract.
PMID 18567994·Mod Pathol·2008
8-other
Re: High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.
PMID 18813329·Mod Pathol·2008
8-other
The current status of traumatic diaphragmatic injury: lessons learned from 105 patients over 13 years.
PMID 18291194·Ann Thorac Surg·2008
8-other
The role of cytokeratin 5/6 as an adjunct diagnostic tool in breast core needle biopsies.
PMID 18499686·Int J Surg Pathol·2008
8-other
Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls.
PMID 18466613·BMC Cancer·2008
8-other
Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
PMID 18500266·Mod Pathol·2008
8-other
Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
PMID 17984188·J Clin Oncol·2007
8-other
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
PMID 19548375·Arch Pathol Lab Med·2007
6-review
Standardization of HER2 testing: results of an international proficiency-testing ring study.
PMID 17396141·Mod Pathol·2007
4-observational
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.
PMID 17475962·J Nucl Med·2007
3-trial
Triple-negative breast cancer: clinical features and patterns of recurrence.
PMID 17671126·Clin Cancer Res·2007
8-other
Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer.
PMID 17710207·Curr Oncol·2007
8-other
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study.
PMID 17922920·Breast Cancer Res·2007
4-observational
A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
PMID 17944726·J Cutan Pathol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 N 1900 E, 1C026
SALT LAKE CITY, UT 84132 - Phone
- (801) 581-2730
Quick Facts
- NPI
- 1457610651
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile